Stock Updates

How has Eli Lilly and Company:(NYSE:LLY) performed recently?

Eli Lilly and Company (NYSE: LLY) is a large market cap stock with a market cap of 88711.72. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 36.69, a forward P/E of 20.02 and EPS of 2.18. At a stock price of 79.77 (-0.23%) it has a dividend yield of 2.55%.

EPS growth for the last five years have been -13.20%, more recently this last year it has grown by 1.60%. The next year growth is going to be about 11.97% and more long-term 12.87% after five years. EPS growth quarter over quarter is -16.60%. Sales growth for the past five years have been -2.90% and sales growth quarter over quarter is 4.70%.

For performance, Eli Lilly and Company the past week has seen a gain of 1.02%. For the last month performance for Eli Lilly and Company is 7.68%. While the last quarter is 4.23% and half year, -0.24%. Finally for the year, performance is -6.09%.

The 52-week high for Eli Lilly and Company, is at -12.36%, and for the 52-week low it comes to a value of 18.30%. The 20-day simple moving average is 4.89% and 3.08% for the 200-day simple moving average.

Volatility for the week is at 1.17%, and for the month it is 1.83%. Eli Lilly and Company, has a target price of 95.67.

In terms of debt, long term debt/equity is 0.5, and for total debt/equity Eli Lilly and Company has 0.54. The gross margin is 74.40%, while operating margin is 13.40%, the profit margin is 11.50%. The current ratio is 1.6 and the quick ratio is 1.1.

Insider ownership is at 11.60%, with instituitional ownership at 76.40%. Eli Lilly and Company has a payout ratio of 96.60%. With the total shares outstanding coming to 1109.59. The shares float is 1102.23, with the float short at 0.83%, with short ratio coming to 2.19.

In terms of returns, the return on assets see Eli Lilly and Company, get 6.50%, with its returns on investment at 9.50%. Return on equity is 15.60%. So will the investors see the target price of 95.67, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment